Vascular Neurocognitive Disorder
Resources for Patients and Caregivers
Vascular neurocognitive disorder is a condition characterized by disruptions in the brain’s blood supply that lead to impairment of one or more aspects of a person’s conscious brain functions.
Cluster Number:
Wiki Number: 56-Vascular Neurocognitive Disorder
Diagnosis:
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms:
Progression:
Causes:
Medications:
Therapies:
Youtube Video:
Normal Aging, Mild Cognitive Impairment, and Dementia
Amazon or Library Books: Dementia Home Care
Click the book to link or order from Amazon.
Support Group: dementiasociety.org; 800-336-3684
(Dementia Society of America)
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injuryby Yuhao Xu on May 8, 2024
CONCLUSIONS: ADORA3 antagonist alleviates chronic ischemic WMI by modulating myelin clearance of microglia, which may be a potential therapeutic target for the treatment of VaD.
- China Initiative for Multi-Domain Intervention (CHINA-IN-MUDI) to Prevent Cognitive Decline: Study Design and Progressby S-Y Li on May 6, 2024
CONCLUSIONS: This project will contribute to the evaluation of the effectiveness and safety of intervention strategies in controlling AD risk and reducing clinical events, providing a basis for public health decision-making in China.
- The Multi-domain Lifestyle Intervention for Cognitive Impairment in Community-Dwelling Older Adults in Hangzhou (The Heritage Study): Study Design and Protocolby X Xu on May 6, 2024
CONCLUSIONS: Following the Worldwide-FINGERS, this cluster RCT will verify the adaptability of the multi-domain lifestyle intervention in the urban community settings in China. This study will add evidence for global dementia prevention and management among older adults.
- Association of Vascular Endothelial Growth Factor Levels with Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysisby S S Zakariaee on May 6, 2024
CONCLUSION: The results show that the serum VEGF concentrations increased for Alzheimer's patients in accordance with the increased expression of VEGF and the VEGF levels of Alzheimer's patients decreased by increasing their disease severities. Therefore, in addition to detecting AD in the earliest stages of the disease, serum VEGF could be a promising biomarker to follow up on the disease and evaluate the clinical course of the disease.